Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: Evaluation of efficacy, tolerance and cost

Journal of Clinical Pharmacy and Therapeutics

Volumn 26, Issue 6, 2001, Pages 445-451

  Bernard, L ^a,b   El hajj, ^a   Pron, B ^a   Lotthe A ^a   Gleizes, V ^a   Signoret, F ^a   Denormandie, ^a   Gaillard, J L ^a   Perronne, C ^a  

^a Raymond Poincaré Medical University   (France)

^b Division of Infectious Diseases   (Switzerland)

Author keywords

Antimicrobial therapy; Cost; Efficacy; Outpatient parenteral osteomyelitis

Indexed keywords

AMPICILLIN; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFTAZIDIME; INFUSOR LV; OXACILLIN; PIPERACILLIN; VANCOMYCIN;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; CATHETER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; FOLLOW UP; HOME CARE; HUMAN; INFUSION; MALE; OSTEOMYELITIS; OUTPATIENT CARE; SIDE EFFECT; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CATHETERS, INDWELLING; DRUG COSTS; FEMALE; HEALTH CARE SURVEYS; HOME CARE SERVICES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; OSTEOMYELITIS; OUTPATIENTS; QUALITY OF LIFE; SELF ADMINISTRATION; TREATMENT OUTCOME;

EID: 0035723406     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.2001.00380.x     Document Type: Article

References (36)

1. Medical coverage of outpatient ambulatory antibiotic therapy: A program that pays itself
2. Place of parenteral cephalosporins in the ambulatory setting: Clinical evidence
3. Feasibility of an outpatient and home parenteral antibiotic therapy program in Tayside, Scotland
4. Osteomyelitis. Diagnosis and special management options
5. Osteomyelitis
6. Osteomyelitis
7. Continuous infusion of β-lactam antibiotics
8. Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantation
9. Financial impact of a home intravenous antibiotic program on a medicare managed care program
10. Pharmacoeconomic considerations in the ambulatory use of parenteral cephalosporins
11. Bone and joint infection
12. A clinical staging system of adult osteomyelitis system
13. Serum bactericidal activity as a monitor of antibiotic therapy
14. New quinolones in the treatment of joint and bone infections
15. Oral ciprofloxacin compared with parenteral antibiotics in the treatment of osteomyelitis
16. Adverse effect of outpatient parenteral antibiotic therapy
17. Unit. Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies
18. Pharmacodynamics of ceftazidime administered as intermittent bolus or constant infusion alone and in combination with single-daily-dose amikacin against Pseudomonas aeruginosa ATCC 27853 in an in vitro infection model
19. Killing and regrowth of bacteria in vitro: A review
20. Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model
21. Influence of four modes of administration on penetration of aztreonam, cefuroxime, and ampicillin into interstitial fluid and fibrin clots and on in vivo efficacy against Haemophilus influenzae
22. Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models
23. Therapeutic efficacy of continuous versus intermittent administration of ceftazidim in an experimental Klebsiella pneumoniae pneumonia in rats
24. Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats
25. Continuous infusion of ceftazidim in cystic fibrosis
26. Treatment of gram-negative bacillary septicemia with cefoperazone
27. Is continuous infusion of B-lactam antibiotics worthwhile? Efficacy and pharmacokinetic considerations
28. J. Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented Gram-Positive infections
29. Vers la perfusion continue de vancomycine en réanimation?
30. Serum bactericidal test
31. Multicenter collaborative evaluation of a standardized serum bactericidal test as a predictor of therapeutic efficacy in acute and chronic osteomyelitis
32. Patient care issues in outpatient intravenous antibiotic therapy
33. Preferences for home vs hospital care among low-risk patients with community-acquired pneumonia
34. Outpatient intravenous antibiotic therapy in Medicare patients: Cost-savings analysis
35. Parenteral cephalosporin therapy in ambulatory care: Advantages and disadvantages
36. Outpatient parenteral antimicrobial therapy for central nervous system infections